Company: IPSC
Filing Date: 2025-03-20
Form Type: S-8
Source: 0001104659-25-025838
Chunk: 0

Company: Century Therapeutics, Inc.
Filing Date: 2025-03-20
Form: S-8
Chunk 0
---
<div align='center'>As filed with the United States Securities and Exchange Commission on March 20, 2025</div>

Registration No. 333-

<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-8

REGISTRATION STATEMENT

Under

THE SECURITIES ACT OF 1933

CENTURY THERAPEUTICS, INC.

(Exact Name of Registrant as Specified in its Charter)</div>

| Delaware                                         | 84-2040295                          |
| (State or other jurisdiction of incorporation or 
 organization)                                    | -I.R.S. Employer Identification No. |

<div align='center'>25 North 38th Street, 11 thFloor

Philadelphia, Pennsylvania 19104

(267) 817-5790(Address, including zip code, of principal executive offices)

CENTURY THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN

(Full title of the plans)

Brent Pfeiffenberger, Pharm.D.

President and Chief Executive Officer

Century Therapeutics, Inc.

25 North 38th Street, 11 thFloor

Philadelphia, Pennsylvania 19104

(267) 817-5790(Name, address and telephone number, including area code, of agent for service)

Copies to:

Rachael M. Bushey
Jennifer Porter

Justin PlattGoodwin Procter LLP

3025 John F Kennedy Blvd

Philadelphia, PA 19104

(445) 207-7805</div>

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Securities Exchange Act of 1934, asamended (the “”).

| Large                                                                                                                                    
 accelerated filer ¨                                                                                                                      | Accelerated 
 filer ¨     | Non-accelerated 
 filer x         | Smaller              
 reporting company  x | Emerging         
 growth company x |
| If                                                                                                                                       
 an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying 
 with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of